Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Researchers at Yale University have identified a new approach to the treatment of osteoarthritis, which goes beyond pain relief. The lacosamide drug, approved for epilepsy, has demonstrated potential to block a protein...